Controlling an Unprecedented Outbreak with Vancomycin-Resistant

hospital outbreak infection prevention and control measures transmission vancomycin-resistant enterococci whole-genome analysis

Journal

Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893

Informations de publication

Date de publication:
09 Aug 2022
Historique:
received: 30 06 2022
revised: 03 08 2022
accepted: 03 08 2022
entrez: 26 8 2022
pubmed: 27 8 2022
medline: 27 8 2022
Statut: epublish

Résumé

Hospital outbreaks with vancomycin-resistant enterococci (VRE) pose a serious health threat and a challenge to infection prevention and control (IPC). We herein report on a VRE outbreak of unprecedented extent in Southern Germany (October 2015-November 2019). We used descriptive epidemiology and whole-genome sequencing (WGS) for a detailed outbreak investigation. Of the 2905 cases, 2776 (95.3%) were colonized, whereas from 127 (3.7%), VRE could be isolated from otherwise sterile body fluids or sites unlikely for enterococci colonization. Cases had a median age of 78 years (IQR 68-84) and 1339/2905 (46%) were female. The majority of isolates sequenced belonged to the clonal lineage ST80/CT1013 (212/397, 53%). Nosocomial transmission was observed as well as the constant import of VRE into the hospital. Extensive IPC measures were implemented and terminated the outbreak in late 2019, eventually. Our study shows that the combination of epidemiological and genomic analyses is indispensable for comprehensive outbreak investigations. The adaptation of IPC measures to these findings, their timely implementation, and strict execution also allow containment of large VRE outbreaks in hospital settings.

Identifiants

pubmed: 36014021
pii: microorganisms10081603
doi: 10.3390/microorganisms10081603
pmc: PMC9412439
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Int J Hyg Environ Health. 2004 Sep;207(4):386-9
pubmed: 15471103
Antimicrob Resist Infect Control. 2022 Mar 12;11(1):48
pubmed: 35279207
J Pediatr Hematol Oncol. 2012 Oct;34(7):511-6
pubmed: 22627577
Infect Dis Health. 2019 May;24(2):82-91
pubmed: 30638872
Biol Blood Marrow Transplant. 2007 May;13(5):615-21
pubmed: 17448922
Heliyon. 2017 Dec 28;3(12):e00473
pubmed: 29322099
Braz J Infect Dis. 2011 Jul-Aug;15(4):403-5
pubmed: 21861018
PLoS One. 2020 Jun 24;15(6):e0235160
pubmed: 32579600
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Oct;61(10):1310-1361
pubmed: 30229318
Int J Environ Res Public Health. 2021 Jan 23;18(3):
pubmed: 33498701
Antimicrob Agents Chemother. 2019 Apr 25;63(5):
pubmed: 30782988
Antimicrob Resist Infect Control. 2018 Jan 5;7:1
pubmed: 29312658
Am J Infect Control. 2008 Apr;36(3):206-11
pubmed: 18371517
Open Forum Infect Dis. 2016 Dec 07;4(1):ofw246
pubmed: 28480243
Clin Infect Dis. 2020 May 23;70(11):2336-2343
pubmed: 31312842
Lancet. 2001 Mar 17;357(9259):855-6
pubmed: 11265957
Euro Surveill. 2021 Nov;26(45):
pubmed: 34763754
Antimicrob Resist Infect Control. 2020 Sep 22;9(1):154
pubmed: 32962759
Sci Rep. 2019 Aug 15;9(1):11917
pubmed: 31417140
Antimicrob Resist Infect Control. 2019 Jul 29;8:128
pubmed: 31384433
mBio. 2013 Aug 20;4(4):
pubmed: 23963180
Clin Infect Dis. 1999 Sep;29(3):573-9
pubmed: 10530450
Genome Res. 2016 Oct;26(10):1388-1396
pubmed: 27527616
Antimicrob Resist Infect Control. 2021 Feb 18;10(1):38
pubmed: 33602300
Lancet Microbe. 2022 Feb;3(2):e133-e141
pubmed: 35146465
J Mol Evol. 1983;19(2):153-70
pubmed: 6571220
J Hosp Infect. 2018 Dec;100(4):e216-e225
pubmed: 29475013
Antimicrob Resist Infect Control. 2020 Jul 16;9(1):109
pubmed: 32678047
Emerg Infect Dis. 2008 Feb;14(2):317-9
pubmed: 18258130
Clin Microbiol Infect. 2006 Feb;12(2):163-9
pubmed: 16441455
J Antimicrob Chemother. 2015 Sep;70(9):2474-82
pubmed: 26031466
Antimicrob Resist Infect Control. 2018 Jul 18;7:86
pubmed: 30034798
Genome Med. 2021 Mar 30;13(1):52
pubmed: 33785076
Infect Control Hosp Epidemiol. 2020 Jan;41(1):1-18
pubmed: 31767041
J Antimicrob Chemother. 2008 May;61(5):1033-9
pubmed: 18319236

Auteurs

Jennifer K Bender (JK)

Nosocomial Pathogens and Antibiotic Resistances Unit, Department of Infectious Diseases, Robert Koch Institute, 38855 Wernigerode, Germany.

Julia Hermes (J)

Healthcare-Associated Infections, Surveillance of Antibiotic Resistance and Consumption Unit, Department of Infectious Disease Epidemiology, Robert Koch Institute, 13353 Berlin, Germany.

Lutz T Zabel (LT)

Alb Fils Kliniken GmbH, 73035 Göppingen, Germany.

Sebastian Haller (S)

Healthcare-Associated Infections, Surveillance of Antibiotic Resistance and Consumption Unit, Department of Infectious Disease Epidemiology, Robert Koch Institute, 13353 Berlin, Germany.

Nadja Mürter (N)

Local Health Authority Göppingen, 73033 Göppingen, Germany.

Hans-Peter Blank (HP)

Charité Comprehensive Cancer Center, 10117 Berlin, Germany.

Guido Werner (G)

Nosocomial Pathogens and Antibiotic Resistances Unit, Department of Infectious Diseases, Robert Koch Institute, 38855 Wernigerode, Germany.

Ingo Hüttner (I)

Alb Fils Kliniken GmbH, 73035 Göppingen, Germany.

Tim Eckmanns (T)

Healthcare-Associated Infections, Surveillance of Antibiotic Resistance and Consumption Unit, Department of Infectious Disease Epidemiology, Robert Koch Institute, 13353 Berlin, Germany.

Classifications MeSH